¼¼°èÀÇ ÀÇ·á¿ë °¡½º ºí·»´õ ½ÃÀå
Medical Gas Blenders
»óǰÄÚµå : 1794449
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 273 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÇ·á¿ë °¡½º ºí·»´õ ½ÃÀåÀº 2030³â±îÁö 25¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 20¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÀÇ·á¿ë °¡½º ºí·»´õ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 4.1%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 25¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ µà¾ó ÇÃ·Î¿ì °¡½º ºí·»´õ´Â CAGR 5.0%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 16¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Æ©ºê ÇÃ·Î¿ì °¡½º ºí·»´õ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 2.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5¾ï 3,640¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á¿ë °¡½º ºí·»´õ ½ÃÀåÀº 2024³â¿¡ 5¾ï 3,640¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³â¿¡ CAGR 7.8%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â 5¾ï 1,810¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.6%¿Í 3.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÇ·á¿ë °¡½º ºí·»´õ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÇ·á¿ë °¡½º ºí·»´õ´Â È£Èí±â °ü¸®ÀÇ Á¤È®¼º°ú ¾ÈÀü¼ºÀ» ¾î¶»°Ô Áö¿øÇϴ°¡?

ÀÇ·á¿ë °¡½º ºí·»´õ´Â È£Èí ¿ä¹ý ¹× ¸¶Ãë Àü´Þ¿¡ Áß¿äÇÑ ±¸¼º ¿ä¼Ò·Î, ÀÇ·áÁøÀÌ È¯ÀÚÀÇ Æ¯Á¤ ¿ä±¸ »çÇ׿¡ µû¶ó »ê¼Ò, °ø±â µî ÀÇ·á¿ë °¡½º¸¦ Á¤È®ÇÏ°Ô È¥ÇÕÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ƯÈ÷ ½Å»ý¾Æ ÁßȯÀÚ½Ç, ¼ö¼ú½Ç, °í»ê¼Ò ¹× Àú»ê¼ÒÁõÀ¸·Î ÀÎÇÑ ÇÕº´ÁõÀ» ÇÇÇϱâ À§ÇØ Á¤È®ÇÑ Åõ¿©°¡ Áß¿äÇÑ ÀÀ±Þ ȯ°æ¿¡¼­ Á¦¾îµÈ »ê¼Ò ³óµµ¸¦ À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¼öµ¿ ºí·»µù ¹× ½Ç¸°´õ È¥ÇÕ°ú ´Þ¸® ÃֽŠÀÇ·á¿ë °¡½º ºí·»´õ´Â Á¤È®Çϰí ÀϰüµÈ Ãâ·Â ºñÀ²À» Á¦°øÇϸç, ÀÌ´Â ¹Ì¼÷¾Æ ¹× ¸¸¼º È£Èí±â Áúȯ ȯÀÚ¸¦ Æ÷ÇÔÇÑ Ãë¾àÇÑ È¯ÀÚ¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÇöÀç ¸¹Àº ¹Í¼­±â¿¡´Â ¾ÈÀü °æº¸, À¯·®°è, ¹é¾÷ ½Ã½ºÅÛÀÌ ³»ÀåµÇ¾î ÀÖÀ¸¸ç, °©ÀÛ½º·± ¾Ð·Â ÀúÇϳª °ø±Þ ºÎÁ· ½Ã¿¡µµ Áß´Ü ¾øÀÌ ÀÛµ¿ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉÀº ÀÎÀ§ÀûÀÎ ½Ç¼ö¸¦ Å©°Ô ÁÙ¿© ȯÀÚÀÇ ¿¹ÈÄ °³¼±¿¡ ±â¿©ÇÕ´Ï´Ù. COPD, õ½Ä, Æó¼¶À¯Áõ µî È£Èí±â ÁúȯÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼¹ÐÇÏ°Ô Á¦¾îµÈ È£Èí º¸Á¶¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, °¡½º ºí·»´õ´Â ÁßȯÀڽǰú ÀÏ¹Ý º´µ¿¿¡¼­ ÇʼöÀûÀÎ ÅøÀÌ µÇ°í ÀÖ½À´Ï´Ù. °íÀ¯·® »ê¼Ò ¿ä¹ý°ú ºñħ½ÀÀû ȯ±â Àü·«ÀÌ Á¤È®ÇÑ °¡½º °ø±Þ¿¡ Å©°Ô ÀÇÁ¸ÇÏ´Â COVID-19¿Í °°Àº ¼¼°è º¸°Ç ºñ»ó»çÅ¿¡ µû¶ó ±× ¿ªÇÒÀÌ ´õ¿í Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á¿ë °¡½º ºí·»´õ´Â È£Èí Ä¡·áÀÇ Ç¥ÁØÀÌ °è¼Ó ÁøÈ­ÇÏ´Â °¡¿îµ¥ ÀÓ»óÀÇ¿¡°Ô ´Ù¾çÇÑ È¯ÀÚ Áý´Ü¿¡ ¾ÈÀüÇϰí È¿°úÀûÀÎ Ä¡·á¸¦ Á¦°øÇÏ´Â µ¥ ÇÊ¿äÇÑ ±â¼úÀû º¸Áõ°ú ¿î¿µ»óÀÇ À¯¿¬¼ºÀ» Á¦°øÇÕ´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº °¡½º ºí·»´õÀÇ ¼º´É°ú »ç¿ë ÆíÀǼºÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±Þ¼ÓÇÑ ±â¼ú ¹ßÀüÀº ÀÇ·á¿ë °¡½º ºí·»´õÀÇ ±â´É¼º, Á¤È®¼º, »ç¿ë ÆíÀǼºÀ» Å©°Ô Çâ»ó½ÃÄÑ º¹ÀâÇÑ ÀÇ·á ȯ°æ¿¡ ´ëÇÑ ÀûÀÀ¼ºÀ» ³ô¿´½À´Ï´Ù. µðÁöÅÐ ¹× ÀüÀÚ½Ä °¡½º ºí·»´õ´Â Á¤È®µµ Çâ»ó, ÇÁ·Î±×·¡¹Ö °¡´ÉÇÑ ¼³Á¤, º´¿ø Á¤º¸ ½Ã½ºÅÛ°úÀÇ ÅëÇÕ ±â´ÉÀ¸·Î ÀÎÇØ ±âÁ¸ ±â°è½Ä ¸ðµ¨º¸´Ù °¢±¤À» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ »õ·Î¿î ¸ðµ¨Àº ÅÍÄ¡½ºÅ©¸° ÀÎÅÍÆäÀ̽º, ¸ÂÃãÇü ¾Ë¶÷, À¯·® ¹× »ê¼Ò ³óµµ ½Ç½Ã°£ ¸ð´ÏÅ͸µ, ÀÓ»óÀǰ¡ ´õ ³ôÀº Á¦¾î¿Í ÀλçÀÌÆ®À¸·Î Ä¡·á¸¦ ¹Ì¼¼ Á¶Á¤ÇÒ ¼ö ÀÖ´Â ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ÀÚµ¿È­ ±â´ÉÀ» ÅëÇØ ¼öÀÛ¾÷ÀÇ ºÎ´ã°ú ÀÎÀû ¿À·ùÀÇ À§ÇèÀ» ÁÙÀ̰í, ³»ÀåµÈ ±³Á¤ ½Ã½ºÅÛÀ» ÅëÇØ Àå±âÀûÀÎ ¼º´ÉÀÇ ½Å·Ú¼ºÀ» À¯ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ³»±¸¼º°ú ³»½Ä¼ºÀÌ ¶Ù¾î³­ ¼ÒÀç¿Í ¸ðµâ½Ä ¼³°è¸¦ äÅÃÇÏ¿© ÀåºñÀÇ ¼ö¸íÀ» ¿¬ÀåÇϰí À¯Áöº¸¼ö ÀýÂ÷¸¦ °£¼ÒÈ­Çß½À´Ï´Ù. ÀϺΠ°í±Þ ½Ã½ºÅÛ¿¡´Â µà¾ó ÇÃ·Î¿ì ±â´ÉÀÌ ÀÖÀ¸¸ç, µÎ ¸íÀÇ È¯ÀÚ³ª Àåºñ¿¡ µ¿½Ã¿¡ °¡½º¸¦ °ø±ÞÇÒ ¼ö ÀÖ´Â ½Ã½ºÅÛµµ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿Ü·¡ ÀÇ·á, ÀçÅà ȯ°æ, ¾ßÀüº´¿ø¿¡¼­ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ¼ÒÇü, °æ·® ¼³°è¸¦ ÅëÇØ È޴뼺¿¡µµ Èû¾²°í ÀÖ½À´Ï´Ù. ÀüÀÚÀǹ«±â·Ï ¹× ½º¸¶Æ® ÀΰøÈ£Èí±â ½Ã½ºÅÛ°úÀÇ ÅëÇÕµµ º¸ÆíÈ­µÇ¾î ¿øÈ°ÇÑ µ¥ÀÌÅÍ ±³È¯°ú ȯÀÚ °ü¸® Àü¹ÝÀÇ Çâ»óÀ» ½ÇÇöÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÒ »Ó¸¸ ¾Æ´Ï¶ó, ¾ÈÀü ±âÁØ ¹× ¿î¿µ ÇÁ·ÎÅäÄÝÀÇ Áؼö¸¦ Çâ»ó½Ãŵ´Ï´Ù. ÀÇ·á ±â°üÀÌ µðÁöÅÐ ÀÇ·á ÀÎÇÁ¶ó¸¦ Çö´ëÈ­ÇÏ°í µµÀÔÇÏ´Â °¡¿îµ¥, ±â¼úÀûÀ¸·Î Áøº¸ÇÑ °¡½º ºí·»´õ´Â °³ÀÎÈ­µÇ°í È¿À²ÀûÀÌ¸ç ½Å¼ÓÇÑ È£Èí Ä¡·á¸¦ Á¦°øÇÏ´Â µ¥ ÇʼöÀûÀÎ Åø·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

ºí·»´õÀÇ ÀÓ»ó Àû¿ë°ú ÀÇ·á ȯ°æÀº ºí·»´õ äÅÿ¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?

ÀÇ·á¿ë °¡½º ºí·»´õÀÇ Ã¤ÅÃÀº µµÀԵǴ ÀÓ»ó ¾ÖÇø®ÄÉÀÌ¼Ç ¹× ÀÇ·á ȯ°æ¿¡ µû¶ó Å©°Ô ´Þ¶óÁý´Ï´Ù. ¿¹¸¦ µé¾î ½Å»ý¾Æ ÁßȯÀڽǿ¡¼­´Â »ê¼Ò ¼öÁØÀ» ¾ö°ÝÇÏ°Ô Á¶ÀýÇÏÁö ¾ÊÀ¸¸é ¹ß»ýÇÒ ¼ö ÀÖ´Â ¹Ì¼÷¾Æ ¸Á¸·Áõ°ú °°Àº ÁúȯÀ» ¿¹¹æÇϱâ À§ÇØ Á¤¹ÐÇÑ »ê¼Ò È¥ÇÕÀÌ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ È¯°æÀÇ ºí·»´õ´Â ¸Å¿ì ³·Àº À¯·®À» ¸Å¿ì Á¤È®ÇÏ°Ô Áö¿øÇØ¾ß Çϸç, Á¾Á¾ ºÐ´ç 0.1-3 ¸®ÅÍ ¹üÀ§ÀÇ ¸Å¿ì ³·Àº À¯·®À» Áö¿øÇØ¾ß ÇϹǷΠ°íµµ·Î Àü¹®È­µÈ Àåºñ°¡ ÇÊ¿äÇÕ´Ï´Ù. ÇÑÆí, ¼ö¼ú½Ç°ú ¸¶Ãë ÈÄ Ä¡·á½Ç¿¡¼­´Â ´õ ³ôÀº À¯·®À» ó¸®ÇÒ ¼ö ÀÖ°í ¸¶Ãë±â ¹× ÀΰøÈ£Èí±â¿Í ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ´Â °¡½º ºí·»´õ°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÀ±Þ½Ç°ú ±¸±ÞÂ÷ ¼­ºñ½º¿¡¼­´Â ȯÀÚ ÀÌ¼Û Áß¿¡µµ ´Ù¾çÇÑ Á¶°Ç¿¡¼­ ½Å¼ÓÇÏ°Ô ¹èÄ¡Çϰí Á¶ÀÛÇÒ ¼ö ÀÖ´Â ¼ÒÇüÀÇ °ß°íÇÑ ºí·»´õ°¡ ÇÊ¿äÇÕ´Ï´Ù. Àå±â¿ä¾ç ¹× ÀçÅÃÀÇ·á ȯ°æ¿¡¼­´Â COPD, ¼ö¸é¹«È£ÈíÁõ°ú °°Àº ¸¸¼º »ê¼Ò ¿ä¹ýÀ» Áö¿øÇϱâ À§ÇØ »ç¿ëÇϱ⠽±°í À¯Áöº¸¼ö°¡ ÀûÀº ºí·»´õ°¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯°æÀº °¢°¢ ÀåºñÀÇ ¼º´É, ½Å·Ú¼º, »ç¿ë ÆíÀǼº¿¡ ´ëÇÑ °íÀ¯ÇÑ ¿ä±¸»çÇ×À» °¡Áö°í ÀÖÀ¸¸ç, ±¸¸Å °áÁ¤°ú Á¦Ç° °³¹ß ¿ì¼±¼øÀ§¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. º´¿ø ¹× Ŭ¸®´ÐÀº ÀÓ»ó¿ë °¡½º ºí·»´õ¸¦ ¼±ÅÃÇÒ ¶§ ±³À° ¿ä±¸ »çÇ×, ±âÁ¸ °¡½º °ø±Þ¿ø°úÀÇ È£È¯¼º, ¼­ºñ½º Áö¿øµµ °í·ÁÇÕ´Ï´Ù. ´Ù¾çÇϰí È®´ëµÇ´Â ÀÓ»ó ½Ã³ª¸®¿À´Â ƯÁ¤ ȯÀÚ Ä¡·á ¿öÅ©Ç÷ο쿡 ¸Â°Ô º®°ÉÀÌÇü, µ¶¸³Çü, ÅëÇÕÇü µî ´Ù¾çÇÑ °¡½º ºí·»´õ ±¸¼ºÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á°¡ ´õ¿í Àü¹®È­µÇ°í ȯÀÚ Áß½ÉÈ­µÊ¿¡ µû¶ó ÀÇ·á¿ë °¡½º ºí·»´õÀÇ ´Ù¿ëµµ¼º°ú ÀûÀÀ¼ºÀÌ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë °¡½º ºí·»´õ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

ÀÇ·á¿ë °¡½º ºí·»´õ ½ÃÀåÀÇ ¼ºÀåÀº ÇコÄÉ¾î µ¿Çâ, ±â¼ú Çõ½Å, È£Èí±â Ä¡·áÀÇ Á¤¹Ðµµ¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϸ鼭 ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ù°, õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ, Æó·Å µî È£Èí±â Áúȯ Áõ°¡·Î ÀÎÇØ ¸ðµç ÀÇ·á ¼öÁØ¿¡¼­ Á¦¾îµÈ »ê¼Ò °ø±Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µÑ°, Àα¸ °í·ÉÈ­¿Í ¼ö¼ú ºñÀ² Áõ°¡·Î ÀÎÇØ Á¤È®ÇÑ °¡½º È¥ÇÕ¿¡ ÀÇÁ¸ÇÏ´Â ¸¶Ãë °ø±Þ ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. COVID-19¸¦ Æ÷ÇÔÇÑ È£Èí±â Àü¿°º´ÀÇ ±¤¹üÀ§ÇÑ ¿µÇâÀº °í¼º´É È£Èí±â ÀåºñÀÇ Çʿ伺À» °­Á¶ÇÏ°í ¼±Áø±¹°ú °³¹ßµµ»ó±¹ ¸ðµÎ¿¡¼­ °¡½º È¥ÇÕ±âÀÇ ±ä±ÞÇÑ Á¶´ÞÀ» Ã˱¸Çϰí ÀÖ½À´Ï´Ù. ³Ý°, ¿Ü·¡Áø·á ¹× ÀçÅÃÀÇ·á ¼­ºñ½º Ãß¼¼¿¡ µû¶ó ±âÁ¸ º´¿ø ȯ°æ ¿Ü¿¡¼­µµ ÈÞ´ë°¡ °¡´ÉÇÏ°í »ç¿ëÀÌ Æí¸®ÇÑ ºí·»´õÀÇ »ç¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ²÷ÀÓ¾ø´Â ±â¼ú Çõ½ÅÀº µðÁöÅÐ ÀÎÅÍÆäÀ̽º, ÀÚµ¿È­, Á¤ºñ°¡ ÇÊ¿ä ¾ø´Â ÀÛµ¿ÀÇ °³¼±À» ÅëÇØ °¡½º ºí·»´õ¸¦ ´õ¿í Ä£¼÷Çϰí È¿À²ÀûÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ê¼Ò ¿ä¹ýÀÇ ¾ÈÀü¿¡ ´ëÇÑ ±ÔÁ¦ ¿ä°Ç°ú È£Èí±â Ä¡·áÀÇ ÀÓ»ó ÁöħÀÌ °­È­µÊ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº ÷´ÜÀÌ°í ±ÔÁ¤À» ÁؼöÇÏ´Â ºí·»µù ½Ã½ºÅÛ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Æ¯È÷ ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÇコÄɾî ÀÎÇÁ¶óÀÇ È®ÀåÀº º´¿ø, ÀÀ±Þ½Ç, À̵¿Áø·á¼Ò µîÀÇ ½Å±Ô ¼³Ä¡¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î ȯÀÚ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇÑ Á¤È®ÇÑ °¡½º ¹èÇÕÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÓ»óÀÇÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ µµÀÔ È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃËÁø¿äÀεéÀÌ °áÇÕµÇ¾î ¿ªµ¿ÀûÀÌ°í ºü¸£°Ô ¼ºÀåÇÏ´Â ½ÃÀåÀ» Çü¼ºÇϰí ÀÖÀ¸¸ç, Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ È¯ÀÚ ¸ÂÃãÇü °íǰÁú È£Èí Ä¡·á¸¦ Á¦°øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(µà¾ó ÇÃ·Î¿ì °¡½º ºí·»´õ, Æ©ºê ÇÃ·Î¿ì °¡½º ºí·»´õ), ÃÖÁ¾ »ç¿ë(º´¿ø ÃÖÁ¾ »ç¿ë, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ ÃÖÁ¾ »ç¿ë, Á¦¾à ÃÖÁ¾ »ç¿ë, ±âŸ ÃÖÁ¾ »ç¿ë)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Gas Blenders Market to Reach US$2.5 Billion by 2030

The global market for Medical Gas Blenders estimated at US$2.0 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Dual Flow Gas Blenders, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Tube Flow Gas Blenders segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$536.4 Million While China is Forecast to Grow at 7.8% CAGR

The Medical Gas Blenders market in the U.S. is estimated at US$536.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$518.1 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Medical Gas Blenders Market - Key Trends & Drivers Summarized

How Are Medical Gas Blenders Supporting Precision and Safety in Respiratory Care?

Medical gas blenders are critical components in respiratory therapy and anesthesia delivery, allowing healthcare providers to precisely mix medical gases such as oxygen and air to meet specific patient requirements. These devices are essential in maintaining controlled concentrations of oxygen, particularly in neonatal intensive care units, operating rooms, and emergency settings where exact dosing is crucial to avoid complications from hyperoxia or hypoxia. Unlike manual blending or cylinder mixing, modern medical gas blenders offer accurate and consistent output ratios, which are vital for fragile patients including premature infants or those with chronic respiratory illnesses. Many blenders now feature built-in safety alarms, flow meters, and backup systems that ensure uninterrupted operation even during sudden pressure drops or supply inconsistencies. These features significantly reduce human error and contribute to better patient outcomes. With rising incidences of respiratory conditions such as COPD, asthma, and pulmonary fibrosis, the demand for finely controlled respiratory support is increasing, positioning gas blenders as indispensable tools in intensive care units and general hospital wards alike. Their role has become even more critical in the wake of global health emergencies such as COVID-19, where high-flow oxygen therapy and non-invasive ventilation strategies rely heavily on precise gas delivery. As respiratory care standards continue to evolve, medical gas blenders are providing clinicians with the technological assurance and operational flexibility required to deliver safe and effective treatment across diverse patient populations.

How Are Technological Advancements Enhancing the Performance and Usability of Gas Blenders?

Rapid technological advancements are significantly improving the functionality, precision, and user-friendliness of medical gas blenders, making them more adaptive to complex healthcare environments. Digital and electronic gas blenders are gaining prominence over traditional mechanical models due to their enhanced accuracy, programmable settings, and integration capabilities with hospital information systems. These newer models offer touchscreen interfaces, customizable alarms, and real-time monitoring of flow rates and oxygen concentrations, enabling clinicians to fine-tune treatment with greater control and insight. Automation features reduce manual workload and the risk of human error, while built-in calibration systems help maintain long-term performance reliability. The use of durable, corrosion-resistant materials and modular designs is also extending the lifespan of these devices and simplifying maintenance procedures. Some advanced systems come equipped with dual flow capabilities, allowing simultaneous gas delivery to two patients or devices, which is particularly beneficial in emergency or high-demand settings. Moreover, portability is being addressed through compact and lightweight designs that facilitate use in ambulatory care, home settings, and field hospitals. Integration with electronic medical records and smart ventilator systems is also becoming increasingly common, providing seamless data exchange and better overall patient management. These innovations not only streamline workflows but also improve compliance with safety standards and operational protocols. As medical institutions continue to modernize and adopt digital health infrastructure, technologically advanced gas blenders are emerging as essential tools in providing personalized, efficient, and responsive respiratory care.

How Do Clinical Applications and Healthcare Settings Influence Blender Adoption?

The adoption of medical gas blenders varies widely depending on the clinical applications and healthcare settings in which they are deployed. In neonatal intensive care units, for example, precision oxygen blending is critical for preventing conditions such as retinopathy of prematurity, which can occur if oxygen levels are not tightly regulated. Blenders in these environments must support very low flow rates with extreme accuracy, often in the range of 0.1 to 3 liters per minute, necessitating highly specialized equipment. In contrast, operating rooms and post-anesthesia care units require gas blenders that can handle higher flow rates and integrate seamlessly with anesthesia machines and ventilators. Emergency departments and ambulance services depend on compact, ruggedized blenders that can be rapidly deployed and operated under variable conditions, including during patient transport. In long-term care and home healthcare environments, user-friendly and low-maintenance blenders are favored to support chronic oxygen therapy for conditions such as COPD and sleep apnea. Each of these settings places unique demands on device performance, reliability, and ease of use, influencing purchasing decisions and product development priorities. Hospitals and clinics also consider training requirements, compatibility with existing gas sources, and service support when selecting gas blenders for clinical use. The diverse and expanding range of clinical scenarios underscores the need for a wide array of gas blender configurations, including wall-mounted, standalone, and integrated units, tailored to specific patient care workflows. As healthcare delivery becomes more specialized and patient-centric, the versatility and adaptability of medical gas blenders are becoming increasingly important.

What Are the Main Drivers Fueling the Growth of the Medical Gas Blenders Market?

The growth in the medical gas blenders market is being driven by a combination of healthcare trends, technological innovations, and increased demand for precision in respiratory therapy. First, the global rise in respiratory diseases such as asthma, chronic obstructive pulmonary disease, and pneumonia is creating higher demand for controlled oxygen delivery systems across all levels of care. Second, the aging population and higher rates of surgical interventions are increasing the need for anesthesia delivery systems that rely on precise gas mixing. The widespread impact of respiratory pandemics, including COVID-19, has underscored the necessity of high-performance respiratory equipment, prompting urgent procurement of gas blenders in both developed and developing regions. Fourth, the trend toward outpatient care and home-based medical services is expanding the use of portable and user-friendly blenders outside traditional hospital environments. Continuous technological innovations are making gas blenders more accessible and efficient, with improvements in digital interfaces, automation, and maintenance-free operation. Also, stricter regulatory requirements around oxygen therapy safety and clinical guidelines for respiratory care are encouraging healthcare providers to invest in advanced, compliant blending systems. Further, the expansion of healthcare infrastructure, particularly in emerging markets, is driving new installations in hospitals, emergency rooms, and mobile clinics. Lastly, growing awareness among clinicians regarding the benefits of precise gas blending in improving patient outcomes is contributing to increased adoption. Together, these drivers are shaping a dynamic and rapidly expanding market that plays a vital role in the global healthcare system's ability to deliver high-quality, patient-tailored respiratory care.

SCOPE OF STUDY:

The report analyzes the Medical Gas Blenders market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Dual Flow Gas Blenders, Tube Flow Gas Blenders); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Pharmaceuticals End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â